TYPE 1 DIABETES MELLITUS: AUTOIMMUNE DIABETES
|
|
- Morgan Wilkerson
- 5 years ago
- Views:
Transcription
1 Nov. 14th, 2014 TYPE 1 DIABETES MELLITUS: AUTOIMMUNE DIABETES Bo Kyung Koo CONTENTS 1. Introduction on Type 1 diabetes (T1DM) 2. Pathogenesis of T1DM 3. Immunologic Marker of T1DM 1
2 Diabetes Mellitus Comprised of a variety of disease all characterized by hyperglycemia and tissue changes that result from heterogeneous etiological and pathogenetic factors Stephen Fajans at his Banting Lecture Insulin Secretion & Action (GLUT) Pancreas Muscle 2
3 Discovery of Insulin The Miracle of Insulin Banting, Best, and colleagues went on to purify the hormone insulin from bovine pancreases. The first patient was treated in
4 Glucose Homeostasis 췌장 지방조직 인슐린인슐린글루카곤 간 근육 혈당이 180mg/dL 이상이되면콩팥에서당을재흡수하지못하고소변으로배출 소변에당이검출 공복혈당 신장 DeFronzo RA Ann Intern Med 1999, Wright EM AJPRP 2001 당뇨병 당뇨병의정의 고혈당을특징으로하는대사이상 당뇨병 = 고혈당 인슐린분비부족 인슐린작용이상 당의과잉생산 4
5 Classification of Diabetes Mellitus I. Type 1 diabetes (beta cell destruction, usually leading to absolute insulin deficiency) A. Immune mediated B. Idiopathic II. Type 2 diabetes (may range from predominantly insulin resistance with relative insulin deficiency to a predominantly secretory defect with insulin resistance) III. Other specific types A. Genetic defects of beta cell function B. Genetic defects in insulin action C. Disease of the exocrine pancreas D. Endocrinopathy E. Drug or chemical induced F. Infections G. Uncommon forms of immune mediated diabetes H. Other genetic syndromes associated with diabetes IV. Gestational diabetes mellitus Type 1 Diabetes Mellitus (T1DM) T1DM is the result of interactions of genetic, environmental, and immunologic factors that ultimately lead to the destruction of the pancreatic beta cells and insulin deficiency. Harrison's Principles of Internal Medicine, 18 th Ed. Inflammatory infiltrate of mononuclear cells in an islet from a 2-year old patient with type 1 diabetes of short duration. Mononuclear cells in and around islets are shown by yellow arrows. Gepts, W Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 14:
6 Pancreatic Islets within Pancreas Type 1 Diabetes Control Subjects Slides were stained for insulin (green), TUNEL (for apoptosis; red) and DAPI (for nuclei; blue), and images were taken at 200 magnification. Arrows indicate beta cell apoptosis Meier JJ et al., Diabetologia
7 Summary (I) Insulin plays a key role in glucose uptake and utilization and its homeostasis, which is crucial for life. T1DM is characterized by beta cell destruction, usually leading to absolute insulin deficiency. Type 1A. Immune mediated Type 1B. Idiopathic Temporal model for development of T1DM 7
8 Genetic Considerations The concordance of T1DM in identical twins ranges between 40 and 60% The major susceptibility gene for T1DM is located in the HLA region on chromosome 6. Account for 40 50% of the genetic risk of T1DM Encode the class II MHC molecules which present antigen to helper T cells Which HLA Loci are Involved? ?? + HLA DR and T1DM Alleles DR3 and DR4 associated with T1DM (Present in 95% of patients) DR3: freq. associated with other autoimmune disease DR3/DR4:most susceptible Allele DR2 protects against T1DM HLA DQ and T1DM Caucasian: DQA1*0301-DQB1*0302, DQA1*0501-DQB1*0201, DQA1*0301-DQB1*0201 African American: DQA1*0301-DQB1*0302, DQA1*0501-DQB1*0201, DQA1*0301-DQB1*0201 Asian : DQA1*0301-DQB1-0401, DQA1*0301-DQB1*0303 DQA1: arginine in position 52 DQB1: non-aspartic acid in position 57 8
9 Inherited Susceptibility Loci (Non-HLA loci) Genome association studies have identified at least 20 different genetic loci that contribute susceptibility to T1DM Mimi S. Kim Constantin Polychronakos, HorRes 2005 Inherited Susceptibility Loci LOCUS CHROMOSOME CANDIDATE GENES or MICROSATELLITES IDDM1 6p21 HLA-DQ\DR IDDM2 11p15 INS VNTR IDDM3 15q26 D15s107 IDDM4 11q13 MDU1, ZFM1, RT6, FADD/MORT1, LRP5 IDDM5 6q24-27 ESR, MnSOD IDDM6 18q12-q21 D18s487, D18s64, JK (Kidd locus) IDDM7 2q31 D2s152, IL-1, NEUROD, GALNT3 IDDM8 6q25-27 D6s264, D6s446, D6s281 IDDM9 3q21-25 D3s1303 IDDM10 10p11-q11 D10s193, D10s208, D10s588 IDDM11 14q24.3-q31 D14s67 IDDM12 2q33 CTLA-4, CD28 IDDM13 2q34 D2s137, D2s164, IGFBP2, IGFBP5 IDDM14? NCBI # 3413 IDDM15 6q21 D6s283, D6s434, D6s1580 IDDM16? NCBI # 3415 IDDM17 10q25 D10s1750-D10s1773 OTHERS 9
10 Temporal model for development of T1DM Breakdown in Immune Regulation Expansion of auto-reactive CD4+ and CD8+ T cells 1-3 Autoantibody-producing B lymphocytes 4-6 Activation of the innate immune system that collaborate to destroy the insulin producing β-cells 7-8. Nature 464, DiLorenzo, T. P.&Serreze, D. V. Immunol. Rev. 204, (2005); 2 Burton, A. R. et al. Diabetes 57, (2008); 3 Han, B. et al.j.clin. Invest. 115, (2005); 4. Serreze, D. V. et al. J. Immunol. 161, (1998); 5. Greeley, S. A. et al.nature Med. 8, (2002); 6. Hu, C. Y. et al. J. Clin. Invest. 117, (2007); 7.Zipris, D. et al. J. Immunol. 178, (2007); 8. Devendra, D. et al. Diabetes 54, (2005). 10
11 Nature Reviews Immunology 7, (August 2007) Immune System Balance - Imbalance of T reg cell to effector T cells A sequential loss of tolerance to multiple epitopes in disease progression Thymic T-cell negative selection related to insulin reactivity itself is key to the genetic predisposition towards the disease 1,2 Nature 464, Vafiadis, P. et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nature Genet. 15, (1997). 2. Pugliese, A. et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type I diabetes. Nature Genet. 15, (1997). 11
12 Previously reported Auto-antigen in T1DM Gene Symbol Protein Header Reference GAD2 glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) Baekkeskov et al.,1982 (1) INS insulin Palmer et al., 1983 (2) CA2 carbonic anhydrase II (CA2) Taniguchi et al., 2003 (3) DDC dopa decarboxylase (aromatic L-amino acid decarboxylase) Rorsman et al., 1995 (4) HSPD1 heat shock 60kDa protein 1 (chaperonin) Jones et al., 1990 (5) REG3A regenerating islet-derived 3 alpha Gurr et al., 2002 (6) SLC30A8 (ZnT8A) solute carrier family 30 (zinc transporter), member 8 Wenzlau et al., 2007 (7) ICA1 islet cell autoantigen 1 Bottazo et al., 1974 (8) PTPRN (IA-2A) protein tyrosine phosphatase, receptor type, N Rabin et al., 1994 (9) CPH carboxypeptidase H Castano et al., 1991 (10) PTPRN2 (IA-2β) protein tyrosine phosphatase, receptor type, N polypeptide 2 Kawasaki et al., 1996 (11) SLC2A2 solute carrier family 2 (facilitated glucose transporter), member 2 Inman et al., 1993 (12) TOP2A topoisomerase (DNA) II alpha 170kDa Chang et al., 1996 (13) 1.Baekkeskov S, et al. (1982) Nature 298(5870): ; 2. Palmer JP, et al. (1983)Science 222(4630): ; 3.Taniguchi T, et al. (2003) Pancreas 27(1):26-30; 4.Rorsman F, et al. (1995) Proc Natl Acad Sci U S A 92(19): ; 5.Jones DB, Hunter NR, & Duff GW (1990) Lancet 336(8715): ; 6. Gurr W, et al. (2002) Diabetes 51(2): ; 7.Wenzlau JM, et al. (2007) Proc Natl Acad Sci U S A 104(43): ; 8.Bottazzo GF, Florin-Christensen A, & Doniach D (1974)Lancet 2(7892): ; 9. Rabin DU, et al. (1994) J Immunol 152(6): ; 10.Castano L, Russo E, Zhou L, Lipes MA, & Eisenbarth GS (1991) J Clin Endocrinol Metab 73(6): ; 11. Kawasaki E, Hutton JC, & Eisenbarth GS (1996) Biochem Biophys Res Commun 227(2): ; 12. Inman LR, et al. (1993). Proc Natl Acad Sci U S A 90(4): ; 13. Chang YH, Hwang J, Shang HF, & Tsai ST (1996) Diabetes 45(4): T1D incidence is rising 3-5% per year Due to environmental cause(s) Incidence /100,000/ yr in children aged 0-14 Finland Sweden Colorado Germany REWERS 12
13 T1DM in Europe ~ ~ * Standardized incidence per 100,000 Patterson CC et al., Lancet 2009; *Bruno G et al., Diabetes 2010; TeeäärT et al., Pediatric Diabetes 2010 The worldwide incidence of childhood T1DM The DIAMOND Project Diabetic Medicine
14 Inverse Association between the Rise in Incidence Rate and the Average Rate Patterson CC et al., Lancet 2009 Environmental Factors Prenatal factors Genetic factor HLA genotype Perinatal and Intrauterine Factors Transplacental transmission of antibodies Birthweight 1 Cesarean deliveries 2 Interplay between maternal age and birth order Postnatal factors Breast-feeding 3,4 Cow s milk exposure 3,4 Vitamin D intake 5 Childhood infections 6,7 Obesity 8 Viral infections 9,10 Islet Autoimmunity 1 EURODIAB study group, Diabetes Care 2002; 2 Cardwell CR et al., Diabetologia2008; 3 Kostraba JN et al., Diabetes Care 1994; 4 Vaarala O et al,. J Allergy Clin Immunol 1995; 5 Ponsonby AL et al., Photochem Phtobiol2005; 6 Gale EA, Diabetologia 2002; 7 PengH et al., Rev Endocr Metab Disord2006; 8 FourlanosS et al., Diabetologia 2004; 9 Dahlquist G et al.,. Ann Med 1997; 10 McKinney PA et al, DiabMed2000; 14
15 The main putative environmental factors associated with the risk of T1DM Viral infection Dietary factors Bacteria Mumps virus Rubella virus Enterovirus/cocksakie B virus Cow s milk/bovine serum albumin Wheat proteins Vitamin D deficiency Direct cell killing Mimicry of cell autoantigenes Autoreactive T-cell activation and subsequent cell killing Triggering autoimmune response Mimicry of cell autoantigenes Triggering autoimmune response Lack of possible protective effect Environment al toxins Directly by replicating in and destroying beta cells 15
16 By altering the immunoregulatory network of the host Through molecular mimicry 16
17 Cow s milk and T1DM Structural similarity between BSA derived peptide called ABBOS* and an islet-cell autoantibody(ica69) Early introduction of cow s milk before gut maturation immune response against BSA *ABBOS: antibodies to a 17 a.a. section of the BSA 17
18 Infant diet and beta-cell autoimmunity Norris et al. DAISY 2000 Hazard Ratio 10 Prospective cohort study 27 cases and 1,022 controls 1 breast milk cow's milk meat fruits/veg. cereal gluten 0.1 Adjusted for HLA-DR,DQ and relationship to type 1 diabetic person TRIGR 3-yr Follow-up Results Seroconversion to 1+ Autoantibody 20% TRIGR: Trial to Reduce IDDM in the Genetically at Risk 15% 10% p=0.043 Cow's Milk Formula Casein Hydrolysate 5% n=173 0% Akerblom HK, Diabetologia
19 T lymphocytes (green) in an islet with beta cells (blue) of a patient with long-standing type 1 diabetes (age 42 years, diabetes duration 23 years) Meier et al,. Diabetologia 2005 Mark A Atkinson, George S Eisenbarth, Lancet 2001 Summary (II) Genetic, environmental, and immunologic factors involve in pathogenesis of T1DM. The major susceptibility gene for T1DM is located in the HLA region on chr6. DR3/DR4:most susceptible Auto-reactive T cells play a dominant role in disease initiation and progression. Autoantibodies against autoantigens appear years before clinical symptoms and are valuable markers for identifying high risk individuals 19
20 Diagnosis Immunologic Markers in T1DM Prediction of the course of disease progression Prevention Treatment Auto-antibodies in T1DM Glutamic acid decarboxylase (GAD65) autoantibodies (GADA) Islet cell auto-antibodies (ICA) Tyrosine phophatase like protein (IA-2A) Zinc transporter autoantibodies (ZnT8A) Bottazzo GF Lancet 1974 Steinunn Baekkeskov et al., Nature 1982 Rabin DU et al., J Immunol 1994 Wenzlau JM et al., PNAS 2007 Gepts W, Diabetes
21 Survival Distribution Function in Relation to the Number of Islet Autoantibodies The data in the figure shows that the number of islet autoantibodies determine the rate of progression to the clinical onset of type 1 diabetes mellitus (T1DM). The different lines for 1 4 islet autoantibodies indicates that few individuals with only one islet autoantibody develop T1DM within 5 years. By contrast, about 60% of individuals with four islet autoantibodies have developed T1DM within 5 years. Abbreviation: ab, autoantibody. Lernmark, Å. & Larsson, H. E. Nat. Rev. Endocrinol. 9, (2013); Anti-GAD65 antibodies (GADA) in T1DM Prevalence in T1DM: 65 75% 1,2 Predict the course of disease progression 3,4 alum-formulated recombinant human GAD65 Secondary/tertiary prevention of T1DM Positive effects in preserving residual C-peptide levels 5,6 1.Tridgell DM et al., Diabetes Care 2011, 2.Lampassona V et al., DiabetesCare Zampetti S et al., JCEM 2012, 4. Jin P et al., ClinEndocrinol 2011, 5. Ludvigsson J et al., NEJM 2008, 6 Agardg CD et al., Diabetologia
22 Anti-GAD Ab in Korean Type 2 Diabetic Patients Time-dependent changes in insulin dependency in anti-gad Ab (GADA) Lee SA et al., Diabetic Medicine 2011 Primary Prevention What to treat to prevent islet autoimmunity Avoid cow s milk protein 1 omega-3 fatty acids 2 Oral insulin Knip M et al., Am J Clin Nutr 2011; 2. Stene LC et al,. Am J clin Nutr 2003; 3. Achenbach P et al., Curr Diab Rep 2008; Nature 4. DPT 464, NEJM
23 Casein Hydrolysate or Conventional Cow s Milk-based Formula Diabetologia (2005) 48: Secondary Prevention Nonautoantigen Ciclosporin 1, BCG vaccine 2, Ketotifen 3 fail Autoantigen-specific Nasal insuiln 4 GAD Carel JC et al., J Autoimmun 1996; 2. Huppmann M et al., Diabetes Care 2005; 3. Bohmer K et al., Diabetes Care 1994; 4. Harrison LC et al., Diabetes Care 2004; 5 Agardh CD et al J Diabetes Complications Agardh CD et al Diabetologia2009; 7 Ludvigsson et al NEJM
24 placebo group 4 μg dose group Phase 2, placebo-controlled, dose-escalation clinical trial 47 GADA-positive type 2 diabetic patients 20 μg dose group 100 μg dose group subcutaneous injections of GAD-alum(4 [n=9], 20 [n=8], 100 [n=9] or 500 [n=8] μg) or placebo (n=13) at weeks 1 and 4 of the trial. GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus 334 patients with type 1 diabetes, fasting C-peptide levels of more than 0.3 ng/ml and detectable serum GAD65 autoantibodies Within 3 months after diagnosis, patients were randomly assigned to receive one of three study treatments: four doses of GAD-alum, two doses of GAD-alum followed by two doses of placebo, or four doses of placebo. N Engl J Med 2012;366:
25 Tertiary Prevention: anti-cd20 Monoclonal Antibody Double-blind study in which 87 patients between 8 and 40 years of age who had newly diagnosed type 1 diabetes N Engl J Med 2009;361: Targets of Immune Intervention in T1DM Nature 464,
26 The first case of fulminant type 1 diabetes in Korea A 36-yr-old woman presented with DKA at 36 wks of gestation. Duration of hyperglycemic symptoms < 2 weeks Glucose: 453 mg/dl (25.1 mmol/l) Arterial ph: 7.19 HbA1c: 5.8% C-peptide: 0.09 nmol/l Islet autoantibody: not determined Outcome: fetal demise Park CM et al. J Kor Diabetes Assoc 20:183~188, 1996 Fulminant T1DM A rapidly progressing form of T1DM Imagawa A et al., NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM 2005 CD3 T lymphocytes (green) and glucagon (red); A-D fulminant T1DM, G-H T1DM with GADA; Imagawa A et al., NEJM
27 Fulminant T1DM Lack of autoimmunity It accounts for 15 20% of T1DM with ketosis or ketoacidosis in Japan Fulminant T1DM Autoimmune T1DM P values Age 39.1 ± ± 16.2 < BMI (kg/m 2 ) 20.7± ± 2.8 < FHx of T1DM 1/160 2/135 NS FHx of T2DM 25/119 33/102 NS Other autoimmune ds. 9/85 17/ Duration of Sx (days) 4.4 ± ± 25.1 NS BW loss 3.5 ± ± 3.7 < Flu-like Sx < Asso. with pregnancy GADA 7/145 (4.8%) 114/128 (89.1%) < Imagawa A et al., NEJM 2000; Imagawa A et al., DiabetesCare 2003; NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM 2005 Autoimmunity in Newly Detected T1DM Newly diagnosed Type 1 diabetes (Jan 1999-Jul 2006) N = 99 Fulminant Type 1 diabetes N =7 (7.1%) Non-fulminant Type 1 diabetes N = 92 (92.9%) AutoAb (+) N = 68 (68.7%) AutoAb (-) N = 24 (24.2%) By retrieving data from the Seoul National University Hospital database, we identified all patients newly diagnosed with type 1 diabetes from January 1999 through July Cho YM et al., Diabetologia Nov;50(11):
28 Clinical Course of T1DM LADA in the Korean Population * 749 patients > 20 years of age who first visited the Diabetes Clinic of Seoul National University Hospital 527 patients with duration of diabetes <5 years without evidence of type 1 diabetes *Korean National Diabetes Program Park YS et al., Diabetes Metab Res Rev 2011 Hwangbo Y et al., Diabetes Metab J
29 Summary (III) Immunologic marker might be useful for diagnosis, prediction of prognosis and prevention in T1DM. Intervention targeting auto-antigen or immune modulation is promising for prevention of T1DM. Nature and mechanism of β-cell destruction in human seems to be variable, which results in a broad spectrum of T1DM spanning from fulminant T1DM to LADA. Conclusions T1DM is characterized by beta cell destruction, usually leading to absolute insulin deficiency. Genetic, environmental, and immunologic factors involve in pathogenesis of T1DM. Auto-reactive T cells play a dominant role in disease initiation and progression. Presence of atypical type of T1DM, such as fulminant T1DM(a rapidly progressing T1DM without evidence of autoimmunity) call for further investigations on pathogenesis of T1DM. 29
TYPE 1 DIABETES MELLITUS: AUTOIMMUNE DIABETES
27 th Nov. 2015 TYPE 1 DIABETES MELLITUS: AUTOIMMUNE DIABETES Bo Kyung Koo CONTENTS 1. Introduction on Type 1 diabetes (T1DM) 2. Pathogenesis of T1DM 3. Immunologic Markers in T1DM 4. Atypical T1DM 1 Diabetes
More informationEvgenija Homšak,M.Ph., M.Sc., EuSpLM. Department for laboratory diagnostics University Clinical Centre Maribor Slovenia
Evgenija Homšak,M.Ph., M.Sc., EuSpLM. Department for laboratory diagnostics University Clinical Centre Maribor Slovenia 14th EFLM Continuing Postgraduate Course in Clinical Chemistry and Laboratory Medicine
More informationPart XI Type 1 Diabetes
Part XI Type 1 Diabetes Introduction Åke Lernmark Epidemiology Type 1 diabetes is increasing worldwide and shows epidemic proportions in several countries or regions [1]. There is evidence to suggest that
More information1. PATHOPHYSIOLOGY OF DIABETES MELLITUS
1. PATHOPHYSIOLOGY OF DIABETES MELLITUS Prof. Vladimir Palicka, M.D., Ph.D. Institute for Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, Czech Republic Diabetes mellitus is
More informationINCIDENCE OF CHILDHOOD TYPE 1 DIABETES IN 14 EUROPEAN COUNTRIES INCLUDING ALL NORDIC COUNTRIES
INCIDENCE OF CHILDHOOD TYPE 1 DIABETES IN 14 EUROPEAN COUNTRIES 1989-1998 INCLUDING ALL NORDIC COUNTRIES FINLAND Sardinia SWEDEN NORWAY UK DENMARK ICELAND Estonia France Greece Italy Lithuania Latvia Romania
More informationPrediction and Prevention of Type 1 Diabetes. How far to go?
Prediction and Prevention of Type 1 Diabetes. How far to go? Peter Colman Diabetes and Endocrinology Royal Melbourne Hospital Royal Melbourne Hospital Lancet, Saturday 30 th November 1974; p. 1279-1282
More informationBDC Keystone Genetics Type 1 Diabetes. Immunology of diabetes book with Teaching Slides
BDC Keystone Genetics Type 1 Diabetes www.barbaradaviscenter.org Immunology of diabetes book with Teaching Slides PRACTICAL Trailnet screens relatives and new onset patients for autoantibodies and HLA
More informationImmune system and diabetes. Chairmen: J. Belkhadir (Morocco) N.M. Lalic (Serbia)
Immune system and diabetes Chairmen: J. Belkhadir (Morocco) N.M. Lalic (Serbia) Autoimmunity and prevention of type 1 diabetes R. Mallone (France) Autoimmunity and Prevention of Type 1 Diabetes Roberto
More informationTargeting the Trimolecular Complex for Immune Intervention. Aaron Michels MD
Targeting the Trimolecular Complex for Immune Intervention Aaron Michels MD Disclosures Research Grant from Novartis. Research Grant from NovoNordisk. Take Home Points Type 1 diabetes is an immunologic
More informationCase 2: A 42 year-old male with a new diagnosis of diabetes mellitus. History - 1
Case 2: A 42 year-old male with a new diagnosis of diabetes mellitus Bruce Knutsen, MD Michael Slag, MD Lisa Thomas, RN, CDE Essentia Health Diabetes and Endocrinology Conference October 14, 2011 History
More informationClinical and Laboratory Characteristics of Childhood Diabetes Mellitus: A Single-Center Study from 2000 to 2013
Original Article www.cmj.ac.kr Clinical and Laboratory Characteristics of Childhood Diabetes Mellitus: A Single-Center Study from 2000 to 2013 Tae Hyun Park 1, Min Sun Kim 1,2, * and Dae-Yeol Lee 1,2 1
More informationCase- history. Lab results
Neda Rasouli, M.D. Associate Professor of Medicine Division of Endocrinology, UC Denver VA_ Eastern Colorado Health Care System Case- history 46 y/o AA male with BMI 37 presented in Oct 2001 with polyuria,
More informationWhat is New in Type 1 Diabetes? Prof. Åke Lernmark
What is New in Type 1 Diabetes? Lunds Universitet/CRC Skånes University Hospital SUS Malmö, Sweden 1 What s new in type 1 diabetes? Is the disease still increasing? What is the etiology? What is the pathogenesis?
More informationAtypical and Ketosis Prone Diabetes. Ashok Balasubramanyam, MD Baylor College of Medicine Houston, Texas
Atypical and Ketosis Prone Diabetes Ashok Balasubramanyam, MD Baylor College of Medicine Houston, Texas Atypical Diabetes in the Spectrum Classified as T1D Classified as T2D Auto-immune T1D T2D A- - KPD
More informationIPS Modern management of childhood diabetes mellitus
Modern management of childhood diabetes mellitus Professor Philippe LYSY, MD PhD Pediatric endocrinology and diabetology Institut de Recherche Expérimentale et Clinique Université Catholique de Louvain
More informationWeek 3, Lecture 5a. Pathophysiology of Diabetes. Simin Liu, MD, ScD
Week 3, Lecture 5a Pathophysiology of Diabetes Simin Liu, MD, ScD General Model of Peptide Hormone Action Hormone Plasma Membrane Activated Nucleus Cellular Trafficking Enzymes Inhibited Receptor Effector
More informationJanice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES
Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes
More informationEarly Indications of Type 1 Diabetes
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/early-indications-of-type-1-diabetes/3861/
More information67 year-old Male with Flu-like Symptoms. Jess Hwang 12/6/12
67 year-old Male with Flu-like Symptoms Jess Hwang 12/6/12 HPI Fishing trip with son, had chills/fatigue 4 days later, went on business trip Severe nausea/vomiting x 2 days Found tachypneic, somnolent
More informationDefinition of diabetes mellitus
Diabetes mellitus II - III First and second type of diabetes mellitus Lecture from pathological physiology Oliver Rácz, 2011-2018 Definition of diabetes mellitus Diabetes mellitus is a group of metabolic
More informationGlucose Homeostasis. Liver. Glucose. Muscle, Fat. Pancreatic Islet. Glucose utilization. Glucose production, storage Insulin Glucagon
Glucose Homeostasis Liver Glucose Glucose utilization Glucose production, storage Insulin Glucagon Muscle, Fat Pancreatic Islet Classification of Diabetes Type 1 diabetes Type 2 diabetes Other types of
More informationChapter 11. Prediction of Type 1A Diabetes: The Natural History of the Prediabetic Period
Chapter 11 Prediction of Type 1A Diabetes: The Natural History of the Prediabetic Period Greenbaum et al Diabetes June 11, 212 Fall in C peptide During First 2 Years From Diagnosis: Evidence of at Least
More informationDiabetes: What is the scope of the problem?
Diabetes: What is the scope of the problem? Elizabeth R. Seaquist MD Division of Endocrinology and Diabetes Department of Medicine Director, General Clinical Research Center Pennock Family Chair in Diabetes
More informationType 1 Diabetes and the Environment: a Focus on Dietary Factors
Type 1 Diabetes and the Environment: a Focus on Dietary Factors CHE Partnership Call November 12, 2014 Jill M. Norris, MPH, PhD Professor and Chair Department of Epidemiology Colorado School of Public
More informationPathogenesis of Diabetes Mellitus
Pathogenesis of Diabetes Mellitus Young-Bum Kim, Ph.D. Associate Professor of Medicine Harvard Medical School Definition of Diabetes Mellitus a group of metabolic diseases characterized by hyperglycemia
More informationShort communication. Abstract
Diabetologia (1999) 42: 574±578 Short communication Ó Springer-Verlag 1999 Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset
More informationRay A. Kroc & Robert L. Kroc. BDC Lectureship 2014
Ray A. Kroc & Robert L. Kroc BDC Lectureship 2014 Ray Kroc (Big Mack) 1902-1984 Predominant establisher of the McDonald's Corporation (1961) Philanthropist: Research and treatment of alcoholism, diabetes,
More informationChapter 10. Humoral Autoimmunity 6/20/2012
Chapter 10 Humoral Autoimmunity 6/20/2012 DIPP Populations Study: Quartile Levels Insulin Autoantibodies (6 month post first IAA) and progression to Diabetes Parrika et al Diabetologia 2012 MSD ELECTROCHEMILUMINESCENT
More informationImmune therapy in type 1 diabetes mellitus.
Immune therapy in type 1 diabetes mellitus. Lernmark, Åke; Elding Larsson, Helena Published in: Nature Reviews Endocrinology DOI: 10.1038/nrendo.2012.237 2013 Link to publication Citation for published
More informationUniversità degli Studi di Chieti Clinica Pediatrica. M. Loredana Marcovecchio, Francesco Chiarelli
Università degli Studi di Chieti Clinica Pediatrica UP TO DATE SUL DIABETE M. Loredana Marcovecchio, Francesco Chiarelli Outline An update on T1D & T2D Epidemiology of diabetes Pathogenesis Treatment Complications
More informationDiabetes Mellitus, Type 1 (or Insulin-Dependent Diabetes Mellitus)
Diabetes Mellitus, Type 1 (or Insulin-Dependent Diabetes Mellitus) Pronunciations: (di"ah-be'teez MEL-ih-tus ) Diabetes Mellitus is a chronic condition characterized either by lack of insulin secretion
More informationComparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus
Original article http://dx.doi.org/10.6065/apem.2013.18.2.65 Ann Pediatr Endocrinol Metab 2013;18:65-70 Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients
More informationTHE ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN INTRONIC REGIONS OF ISLET CELL AUTOANTIGEN 1 AND TYPE 1 DIABETES MELLITUS.
THE ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN INTRONIC REGIONS OF ISLET CELL AUTOANTIGEN 1 AND TYPE 1 DIABETES MELLITUS by Carrie Lynn Blout B.S., Dickinson College, 2004 Submitted to the Graduate
More informationGAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes
BRIEF REPORT GAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes Dongmei Miao, K. Michelle Guyer, Fran Dong, Ling Jiang, Andrea K. Steck, Marian Rewers,
More informationDiabetes Mellitus in the Pediatric Patient
Diabetes Mellitus in the Pediatric Patient William Bryant, M.D. Chief of Section Pediatric Endocrinology Children s Hospital at Scott & White Texas A&M University Temple, Texas Disclosures None Definitions
More informationType 1 diabetes in children - risk factors and prediction.
Type 1 diabetes in children - risk factors and prediction. Elding Larsson, Helena 2008 Link to publication Citation for published version (APA): Larsson, H. (2008). Type 1 diabetes in children - risk factors
More informationDiabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE
Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized
More informationImmune Modulation of Type1 Diabetes
Immune Modulation of Type1 Diabetes Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of Miami Miller School of Medicine Ideal Therapeutic
More informationDesigning An)gen- specific Immunotherapy for Treatment of Type 1 Diabetes.
Designing An)gen- specific Immunotherapy for Treatment of Type 1 Diabetes. Kristin V. Tarbell Immune Tolerance Unit, Diabetes Endocrinology and Obesity Branch, NIDDK Outline Background on type 1 diabetes
More informationNew targets for prevention of type 1 diabetes George S. Eisenbarth Barbara Davis Center Unversity Colorado
New targets for prevention of type 1 diabetes George S. Eisenbarth Barbara Davis Center Unversity Colorado WEB BOOK: Immunology of Type 1 Diabetes HTTP://WWW.BARBARADAVISCENTER.ORG Board Member/Advisory
More informationProbiotics for the Prevention of Beta Cell Autoimmunity in Children at Genetic Risk of Type 1 Diabetes the PRODIA Study
Probiotics for the Prevention of Beta Cell Autoimmunity in Children at Genetic Risk of Type 1 Diabetes the PRODIA Study MARTIN LJUNGBERG, a RIITA KORPELA, b JORMA ILONEN, c JOHNNY LUDVIGSSON, a AND OUTI
More informationType 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications. Alejandro J de la Torre Pediatric Endocrinology 10/17/2014
Type 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications Alejandro J de la Torre Pediatric Endocrinology 10/17/2014 Objectives Understand the pathophysiology of Type 1 diabetes. Be familiar
More informationTreatment guideline for adult patients with type 1 diabetes?
Treatment guideline for adult patients with type 1 diabetes? Jae Hyeon Kim Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine ICDM 2014 Treatment
More informationDIABETES MELLITUS. IAP UG Teaching slides
DIABETES MELLITUS 1 DIABETES MELLITUS IN CHILDREN Introduction, Definition Classification, pathogenesis Clinical features Investigations and diagnosis Therapy and follow up Complications Carry home message
More informationCordoba 01/02/2008. Slides Professor Pierre LEFEBVRE
Cordoba 01/02/2008 Slides Professor Pierre LEFEBVRE Clinical Research in Type 2 Diabetes : Current Status and Future Approaches Pierre Lefèbvre* University of Liège Belgium Granada, Spain, February 2008
More informationWhat is Autoimmunity?
Autoimmunity What is Autoimmunity? Robert Beatty MCB150 Autoimmunity is an immune response to self antigens that results in disease. The immune response to self is a result of a breakdown in immune tolerance.
More informationWhat is Autoimmunity?
Autoimmunity What is Autoimmunity? Robert Beatty MCB150 Autoimmunity is an immune response to self antigens that results in disease. The immune response to self is a result of a breakdown in immune tolerance.
More informationb-cell Autoantibodies and Their Function in Taiwanese Children With Type 1 Diabetes Mellitus
ORIGINAL ARTICLE b-cell Autoantibodies and Their Function in Taiwanese Children With Type 1 Diabetes Mellitus Yi-Ching Tung, 1 Mei-Huei Chen, 2 Cheng-Ting Lee, 1 Wen-Yu Tsai 1 * Background/Purpose: To
More informationAntigen-Based Prediction and Prevention of Type 1 Diabetes
DOCTOR OF MEDICAL SCIENCE Antigen-Based Prediction and Prevention of Type 1 Diabetes Jacob Sten Petersen This review has been accepted as a thesis together with ten previously published papers, by the
More informationSignificance of the MHC
CHAPTER 7 Major Histocompatibility Complex (MHC) What is is MHC? HLA H-2 Minor histocompatibility antigens Peter Gorer & George Sneell (1940) Significance of the MHC role in immune response role in organ
More informationSelf-tolerance. Lack of immune responsiveness to an individual s own tissue antigens. Central Tolerance. Peripheral tolerance
Autoimmunity Self-tolerance Lack of immune responsiveness to an individual s own tissue antigens Central Tolerance Peripheral tolerance Factors Regulating Immune Response Antigen availability Properties
More informationDistinguishing T1D vs. T2D in Childhood: a case report for discussion
Distinguishing T1D vs. T2D in Childhood: a case report for discussion Alba Morales, MD Associate Professor of Pediatrics Division of Pediatric Endocrinology and Diabetes Disclosure I have no financial
More informationPregnancy outcomes in Korean women with diabetes
Pregnancy outcomes in Korean women with diabetes Sung-Hoon Kim Department of Medicine, Cheil General Hospital & Women s Healthcare Center, Dankook University College of Medicine, Seoul, Korea Conflict
More informationDiabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016
Diabetes Mellitus Raja Nursing Instructor 09/03/2016 Acknowledgement: Badil Objective: Define Diabetes Mellitus (DM) & types of DM. Understand the pathophysiology of Type-I & II DM. List the clinical features
More informationIslet Cell Autoantibodies in Cord Blood from Children with Blood Group Incompatibility or Hyperbilirubinemia
Autoimmunity, 2003 Vol. 36 (2), pp. 111 115 Islet Cell Autoantibodies in Cord Blood from Children with Blood Group Incompatibility or Hyperbilirubinemia A. MARIA ELFVING a, BENGT A. LINDBERG b, *, M. LANDIN-OLSSON
More informationHormonal Regulations Of Glucose Metabolism & DM
Hormonal Regulations Of Glucose Metabolism & DM What Hormones Regulate Metabolism? What Hormones Regulate Metabolism? Insulin Glucagon Thyroid hormones Cortisol Epinephrine Most regulation occurs in order
More informationDiabetes mellitus is a complex of syndromes characterized metabolically by hyperglycemia and altered glucose metabolism, and associated
Diabetes mellitus is a complex of syndromes characterized metabolically by hyperglycemia and altered glucose metabolism, and associated pathologically with specific microvascular and macrovascular complications.
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationAnti-islet autoantibodies in Japanese type 1 diabetes
15 th Korea Japan Symposium on Diabetes Anti-islet autoantibodies in Japanese type 1 diabetes Eiji Kawasaki, Katsumi Eguchi Nagasaki University Hospital, Nagasaki, Japan November 20 21, 21 2009 Cheju Islend
More informationIDDM1 and Multiple Family History of Type 1 Diabetes Combine to Identify Neonates at High Risk for Type 1 Diabetes
Metabolic Syndrome/Insulin Resistance Syndrome/Pre-Diabetes O R I G I N A L A R T I C L E IDDM1 and Multiple Family History of Type 1 Diabetes Combine to Identify Neonates at High Risk for Type 1 Diabetes
More informationPatients: Adult KPD patients (n 384) were followed longitudinally in a research clinic.
JCEM ONLINE Brief Report Endocrine Research Masked and Overt Autoantibodies Specific to the DPD Epitope of 65-kDa Glutamate Decarboxylase (GAD65- DPD) Are Associated With Preserved -Cell Functional Reserve
More informationTopic (Final-03): Immunologic Tolerance and Autoimmunity-Part II
Topic (Final-03): Immunologic Tolerance and Autoimmunity-Part II MECHANISMS OF AUTOIMMUNITY The possibility that an individual s immune system may react against autologous antigens and cause tissue injury
More informationInfant and Childhood Diet and Type 1 Diabetes Risk: Recent Advances and Prospects
Curr Diab Rep (2010) 10:345 349 DOI 10.1007/s11892-010-0131-5 Infant and Childhood Diet and Type 1 Diabetes Risk: Recent Advances and Prospects Jill M. Norris Published online: 20 July 2010 # Springer
More informationBy: Dr. Doaa Khater Yassin, MM and M.D Paed Sr. specialist of Pediatrics SQUH
By: Dr. Doaa Khater Yassin, MM and M.D Paed Sr. specialist of Pediatrics SQUH Born SGA with birth weight of 2.4 kg, had IUGR Hospitalized at the age of 2 month with severe dehydration Diagnosed as DKA
More informationType I diabetes mellitus. Dr Laurence Lacroix
mellitus Dr Laurence Lacroix 26.03.2014 1 DEFINITION: Group of diseases characterized by a disorder of glucose homeostasis with high levels of blood glucose resulting from defects in : o insulin production
More informationThe enteroinsular axis in the pathogenesis of prediabetes and diabetes in humans
The enteroinsular axis in the pathogenesis of prediabetes and diabetes in humans Young Min Cho, MD, PhD Division of Endocrinology and Metabolism Seoul National University College of Medicine Plasma glucose
More informationMaturity-onset diabetes of the young (MODY) is a heterogeneous group
Over the years, different forms of maturity-onset diabetes of the young (MODY) have been identified, with mutations in a number of different genes associated with a MODY-like phenotype. Depending on the
More informationThe Egyptian Journal of Hospital Medicine (January 2018) Vol. 70 (2), Page
The Egyptian Journal of Hospital Medicine (January 2018) Vol. 70 (2), Page 303-307 The Relation between Breastfeeding and Incidence of Diabetes Mellitus Type I in Saudi Arabia, Cross Sectional Study Alnasyan
More informationASSESSMENT OF THE RISK FOR TYPE 1 DIABETES MELLITUS CONFERRED BY HLA CLASS II GENES. Irina Durbală
ASSESSMENT OF THE RISK FOR TYPE 1 DIABETES MELLITUS CONFERRED BY HLA CLASS II GENES Summary Irina Durbală CELL AND MOLECULAR BIOLOGY DEPARTMENT FACULTY OF MEDICINE, OVIDIUS UNIVERSITY CONSTANŢA Class II
More informationV. N. Karazin Kharkiv National University Department of internal medicine Golubkina E.O., ass. of prof., Shanina I. V., ass. of prof.
V. N. Karazin Kharkiv National University Department of internal medicine Golubkina E.O., ass. of prof., Shanina I. V., ass. of prof., Macharinskaya O.S., ass. of prof; Supervisor: prof. Yabluchanskiy
More informationDr Dario Tuccinardi University Campus Bio-Medico of Rome
Dr Dario Tuccinardi University Campus Bio-Medico of Rome d.tuccinardi@unicampus.it Topics to be discussed Epidemiology (increase in incidence) Genetics (more cases with moderate HLA risk alleles) Pathogenesis
More informationassociated with serious complications, but reduce occurrences with preventive measures
Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences
More informationEarly Onset of Diabetes in the Proband Is the Major Determinant of Risk in HLA. DR3-DQ2/DR4-DQ8 siblings, the
Diabetes Volume 63, March 2014 1041 Kathleen M. Gillespie, Rachel J. Aitken, Isabel Wilson, Alistair J.K. Williams, and Polly J. Bingley Early Onset of Diabetes in the Proband Is the Major Determinant
More informationImmunology Lecture 4. Clinical Relevance of the Immune System
Immunology Lecture 4 The Well Patient: How innate and adaptive immune responses maintain health - 13, pg 169-181, 191-195. Immune Deficiency - 15 Autoimmunity - 16 Transplantation - 17, pg 260-270 Tumor
More informationDOWNLOAD OR READ : TYPE 1 DIABETES IN CHILDREN HOW TO BECOME AN EXPERT ON YOUR OWN DIABETES PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : TYPE 1 DIABETES IN CHILDREN HOW TO BECOME AN EXPERT ON YOUR OWN DIABETES PDF EBOOK EPUB MOBI Page 1 Page 2 type 1 diabetes in children how to become an expert on your own diabetes type
More informationNon-insulin treatment in Type 1 DM Sang Yong Kim
Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay
More informationÄr diabetes mellitus en autoimmun sjukdom? Olle Korsgren
Är diabetes mellitus en autoimmun sjukdom? Olle Korsgren Type 1 Diabetes is currently regarded as a T cell mediated autoimmune disease, a notion expressed in over 50 000 scientific publications. Acute
More informationRisk Factors and Primary Prevention Trials for Type 1 Diabetes
666 Ivyspring International Publisher Research Paper International Journal of Biological Sciences 2013; 9(7):666-679. doi: 10.7150/ijbs.6610 Risk Factors and Primary Prevention Trials for Type 1 Diabetes
More informationEarly Diagnosis of T1D Through An3body Screening
Early Diagnosis of T1D Through An3body Screening Andrea Steck, M.D. Barbara Davis Center for Childhood Diabetes Keystone Conference July 15, 2017 Presenter Disclosure Andrea Steck Disclosed no conflict
More informationAutoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens
Autoimmunity Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens Autoimmune disease can be caused to primary defects in B cells, T cells and possibly
More informationGestational Diabetes Mellitus Dr. Fawaz Amin Saad
Gestational Diabetes Mellitus Dr. Fawaz Amin Saad Senior Consultant OB/GYN, Al-Hayat Medical Center, Doha, Qatar DISCLOSURE OF CONFLICT OF INTEREST I am a full-time Employee at Al-Hayat Medical Center.
More informationPerinatal Nutrition. Disclosure Statement. Annual Meeting of the NASPGHAN. Keynote Lecture: Nutrients in the Perinatal Environment: Lessons Learned
Annual Meeting of the NASPGHAN Chicago, ILL October 10-13, 2013 Keynote Lecture: Nutrients in the Perinatal Environment: Lessons Learned Allan Walker, M.D. Boston, MA Disclosure Statement Dr. Allan Walker
More informationDysregulation of glucose metabolism in preclinical type 1 diabetes
Pediatric Diabetes 2016: 17(Suppl. 22): 25 30 doi: 10.1111/pedi.12392 All rights reserved Pediatric Diabetes Review Article Dysregulation of glucose metabolism in preclinical type 1 diabetes Veijola R,
More informationAn association analysis of the HLA gene region in latent autoimmune diabetes in adults
Diabetologia (2007) 50:68 73 DOI 10.1007/s00125-006-0513-z SHORT COMMUNICATION An association analysis of the HLA gene region in latent autoimmune diabetes in adults M. Desai & E. Zeggini & V. A. Horton
More informationDepleting T cells in newly diagnosed autoimmune (type 1) diabetes--are we getting anywhere?
Depleting T cells in newly diagnosed autoimmune (type 1) diabetes--are we getting anywhere? Lernmark, Åke Published in: Diabetes DOI: 10.2337/db13-1207 Published: 2013-01-01 Link to publication Citation
More informationAutoimmune diagnostics in diabetes mellitus 1)
Clin Chem Lab Med 2006;44(2):133 137 2006 by Walter de Gruyter Berlin New York. DOI 10.1515/CCLM.2006.025 2006/35 Review Autoimmune diagnostics in diabetes mellitus 1) Jochen Seissler* and Werner A. Scherbaum
More informationS1-5 Tables (supplementary results) 3. S1-2 Figures (supplementary results).. 8. Details of the literature review... 10
Infant feeding and risk of type 1 diabetes in two large Scandinavian birth cohorts Authors: Nicolai A. Lund-Blix, Stine Dydensborg Sander, Ketil Størdal, Anne-Marie Nybo Andersen, Kjersti S. Rønningen,
More informationPersonalized therapeutics in diabetes
Personalized therapeutics in diabetes Leen M. t Hart Molecular Cell Biology & Molecular Epidemiology Leiden University Medical Center Epidemiology & Biostatistics VU University Medical Center Diabetes
More informationImmunology - Lecture 2 Adaptive Immune System 1
Immunology - Lecture 2 Adaptive Immune System 1 Book chapters: Molecules of the Adaptive Immunity 6 Adaptive Cells and Organs 7 Generation of Immune Diversity Lymphocyte Antigen Receptors - 8 CD markers
More informationHistory of Investigation
Acini - Pancreatic juice (1º) (2º) Secretions- neuronal and hormonal mechanisms 1) Secretin - bicarbonate rich 2) Cholecystokinin - enzyme rich Islets of Langerhans (contain 4 cell types) Alpha cells (α)-
More informationLundgren, Markus; Lynch, Kristian; Larsson, Christer; Elding Larsson, Helena; Diabetes Prediction in Skåne study group; Carlsson, Annelie
Cord blood insulinoma-associated protein 2 autoantibodies are associated with increased risk of type 1 diabetes in the population-based Diabetes Prediction in Skane study Lundgren, Markus; Lynch, Kristian;
More informationHLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol
HLA and antigen presentation Department of Immunology Charles University, 2nd Medical School University Hospital Motol MHC in adaptive immunity Characteristics Specificity Innate For structures shared
More informationTherapeutic strategy to reduce Glucagon secretion
Clinical focus on glucagon: α-cell as a companion of β-cell Therapeutic strategy to reduce Glucagon secretion Sunghwan Suh Dong-A University Conflict of interest disclosure None Committee of Scientific
More informationThe regenerative therapy of type 1 diabetes mellitus 21April 2017 Girne, Northern Cyprus 53rd Turkish National Diabetes Congress
The regenerative therapy of type 1 diabetes mellitus 21April 2017 Girne, Northern Cyprus 53rd Turkish National Diabetes Congress Thomas Linn Clinical Research Unit Centre of Internal Medicine Justus Liebig
More informationAttribution: University of Michigan Medical School, Department of Microbiology and Immunology
Attribution: University of Michigan Medical School, Department of Microbiology and Immunology License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution
More informationSHORT COMMUNICATION. K. Lukacs & N. Hosszufalusi & E. Dinya & M. Bakacs & L. Madacsy & P. Panczel
Diabetologia (2012) 55:689 693 DOI 10.1007/s00125-011-2378-z SHORT COMMUNICATION The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the
More informationImmune responses in autoimmune diseases
Immune responses in autoimmune diseases Erika Jensen-Jarolim Dept. of Pathophysiology Medical University Vienna CCHD Lecture January 24, 2007 Primary immune organs: Bone marrow Thymus Secondary: Lymph
More information[AUTOIMMUNITY] July 14, 2013
This sheet includes only the extra notes. Slide 5,6: [AUTOIMMUNITY] July 14, 2013 Autoimmunity is the condition or case where the immune system is activated by self antigensand when the immune system no
More informationType 1 and Type 2 Diabetes among Youths in Jordan: Incidence and Trends for the period ( ) Abstract Acknowledgement 1.
Type 1 and Type 2 Diabetes among Youths in Jordan: Incidence and Trends for the period (2011-2016) Dr. Alghtani Fehaid Mohammed N Dr. Alanazi Saqqar Abdulelah S Dr. Alshahrani Adel Mohammed S Dr. Alhejaili
More informationWhat is Diabetes Mellitus?
Normal Glucose Metabolism What is Diabetes Mellitus? When the amount of glucose in the blood increases, After a meal, it triggers the release of the hormone insulin from the pancreas. Insulin stimulates
More information